Biases in judging unanticipated possible effects

Important unanticipated effects of treatments are often first suspected by people using or prescribing treatments. As with anticipated effects of treatments, steps must be taken to reduce biases and the play of chance in assessing suspected unanticipated effects.


JLL Essay
2.6 Reducing biases in judging unanticipated possible treatment effects

Generating and investigating hunches about unanticipated adverse effects of treatments

 

FILTER CLEAR FILTERS

SORT date author


FILTER RECORDS BY


D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS (2021)
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double- blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Annals of Internal Medicine 124:1019-1030.

View

Chalmers I (2017)
The evolution of fair tests of treatments over two millennia: a 23 minute audio commentary. Edited by Hamish Chalmers, using unbroadcast recordings made by Freakonomics Radio, with permission.

View

Newcombe RG (1988)
Explanatory and pragmatic estimates of the treatment effect when deviations from allocated treatment occur. . Statistics in Medicine Volume 7, Issue 11 p. 1179-1186.

View

Robert E, Guibaud P (1982)
Maternal valproic acid and congenital neural tube defects. Lancet 2:937.

View

Venning GR (1982)
Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms. BMJ 284:249-254.

View

Ibrahim MA, Spitzer WO (Editors) (1979)
The Case-Control Study: Consensus and Controversy. New York: Pergamon Press.

View

Jick H, Vessey M (1978)
Case-control studies in the evaluation of drug-induced illness. American Journal of Epidemiology 1978;107:1-7.

View

Colombo F, Shapiro S, Slone D, Tognoni G (1977)
Epidemiological evaluation of drugs. Amsterdam: Elsevier/North-Holland Biomedical Press.

View

Jick H (1977)
The discovery of drug-induced illness. New England Journal of Medicine 296:481-485.

View

Boston Collaborative Drug Surveillance Group (1974)
Regular aspirin intake and acute myocardial infarction. BMJ 1:440-443.

View

Doll R (1969)
Recognition of unwanted effects of drugs. BMJ 2:69-76.

View

Finney DJ (1965)
The design and logic of a monitor of drug use. Journal of Chronic Diseases 18:77-98.

View

McBride WG (1961)
Thalidomide and congenital abnormalities. Lancet 2:1358.

View

Reverdin J-L, Reverdin A (1883)
Note sur vingt-deux opérations de goitre, avec 3 pl. photographiques [Note on twenty two operations on goitre. Continuation and conclusion]. Revue Médicale de la Suisse Romande 3:169-198, 233-278, 309-364.

View

Kocher T (1883)
Ueber Kropfexstirpation und ihre Folgen [On goitre removal, and its consequences]. Archiv für Klinische Chirurgie 29:254-337.

View

Show


Gøtzsche PC (2021).
Citation bias: questionable research practice or scientific misconduct? JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Tröhler U (2010).
Emil Theodor Kocher (1841-1917). JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Jick H (2008).
Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vessey MP (2006).
Learning how to control biases in studies to identify adverse effects of drugs. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vandenbroucke JP (2003).
Aspirin: an unanticipated beneficial effect. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Vandenbroucke JP (2003).
Thalidomide: an unanticipated adverse effect. JLL Bulletin: Commentaries on the history of treatment evaluation.

View

Nothing found, please try resetting your search filters